# 2022

Ljubljana, Slovenia

I-01 João AbrantesADaMO: End-to-end automation of Pharmacometric modelling in drug development, from dataset building to output generationWednesday 09:45-11:15 |

I-02 Nicolas AzzopardiMechanistic model of contrast-enhanced ultrasound in colorectal cancer metastasis. Wednesday 09:45-11:15 |

I-03 Freya BachmannComputing Optimal Drug Dosing with OptiDose: Implementation in NONMEMWednesday 09:45-11:15 |

I-10 Chao ChenThe area under the effect curve as a preclinical-to-clinical translation tool for predicting therapeutic dose of anti-infectivesWednesday 09:45-11:15 |

I-11 Henrik CordesSpecies-specific Expression Databases for Physiologically Based Pharmacokinetic ModelingWednesday 09:45-11:15 |

I-20 Mélanie GuhlComputation of standard errors at finite distance in non linear mixed effects modelsWednesday 09:45-11:15 |

I-24 Laura IavaroneApplication of the Area Under the Effect Curve as in vivo efficacy driver in Visceral LeishmaniasisWednesday 09:45-11:15 |

I-25 Woojin JungContainerized NONMEM and its assistant software in R development environmentWednesday 09:45-11:15 |

I-28 Silvia Maria LavezziTranslational pharmacology benchmarking of a novel drug candidate for an autoimmune diseaseWednesday 09:45-11:15 |

I-32 Nicolas LuyckxCampsis: A generic, easy-to-use and intuitive PK/PD simulation platform based on R packages RxODE and mrgsolveWednesday 09:45-11:15 |

I-35 Frano MihaljevicDevelopment of a level A in vitro/in vivo correlation (IVIVC) using applications of the MonolixSuiteWednesday 09:45-11:15 |

I-39 Marije OttoApplication of Item Response Theory in Early Phase Clinical Trials: Utilization of a Reference Model to Analyse the Montgomery-Åsberg Depression Rating Scale.Wednesday 09:45-11:15 |

I-40 Theodoros PapathanasiouPKPD Exploratory Graphics (xGx) Cheat SheetWednesday 09:45-11:15 |

I-44 Thao Nguyen PhamCombining aggregate data and individual patient/subject data in model-based meta-analysis: An illustrative case study of tofacitinib in rheumatoid arthritis patients Wednesday 09:45-11:15 |

I-48 Christelle RodriguesUsing preclinical data to predict human pharmacokinetics of monoclonal antibodies for first-in-human dose setting: A review of five internal case studies Wednesday 09:45-11:15 |

I-51 Sergio Sánchez HerreroGround-breaking software for modelling, simulation, optimization, estimation and validation applications in drug development timeline processes.Wednesday 09:45-11:15 |

I-58 Pauline TraynardValidation of non-compartmental analysis (NCA) and bioequivalence results of PKanalix with respect to Phoenix WinNonLin and SAS.Wednesday 09:45-11:15 |

I-59 carla troisiPopulation pharmacokinetics of continuous infusion ampicillin in the treatment of enterococcal infections in adult hospitalised patients Wednesday 09:45-11:15 |

I-60 Monika TwarogowskaA library of parent-metabolite models for the MonolixSuiteWednesday 09:45-11:15 |

I-62 Marinda van de KreekeIdentifiability of drug effects in turn-over models with increasing complexityWednesday 09:45-11:15 |